BeiGene and CLL Society Partner to Advance Test Before Treat™ Campaign, Promoting Biomarker Testing to Improve Patient ...

A new review was published in Oncotarget's Volume 15 on November 22, 2024, entitled "Mesenchymal stem cells – the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists." ...

BeiGene, Ltd. , a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced its new partnership with CLL Society, the world's leading authority for chronic ...